Company intelligence / Profile preview

RX Pharmatech

Bradford, West Yorkshire, United Kingdom

Ownership: Private
Employees: ~5
Development stage: Other

Overview

RX Pharmatech specializes in the commercialization of food-grade cannabinoid ingredients, including CBD and CBG isolates, and finished products in the UK and EU. The company secured 1,276 UK Food Standards Agency novel food applications for CBD products, establishing a strong regulatory position for its parent company, 22nd Century Group, and its subsidiary GVB Biopharma. Their products are commercial food-grade ingredients, not pharmaceuticals.

Therapeutic areas: GastroenterologyOther
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

GVB BiopharmaMultinational food and beverage and nutraceutical companies (as contract partners for licensed CBD products)

Beyond the preview

Go deeper on RX Pharmatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RX Pharmatech.

Explore the full profile